CBZ promoted NLRP3 inflammasome activation induced by ATP or nigericin via increasing mtROS production. NLRP3 deficiency in mice protects from the severe liver damage caused by cotreatment of CBZ and LPS. Here, NLRP3 is linked to hyperinsulinemic hypoglycemia, familial, 4.